SciVision Biotech (1786.TW) Stock Price

SciVision Biotech Price

TWSE·CLOSED
49.70TWD+0.15 (+0.30 %)
Market closed

Over the last 18 years SciVision Biotech grew revenue by 26.5% annually, reaching 886.62 M TWD. Earnings per share have grown at 6.1% per year over the last 14 years. For SciVision Biotech, the net margin of 18.3% is down versus 20.1% a few years ago. At today's price the dividend yield works out to roughly 6.52%. The payout ratio is around 146% of earnings. The dividend has grown at 15.7% per year over the past 11 years. The consensus 12-month price target for SciVision Biotech is 148.92 TWD, about 199.6% above where the stock trades today. Of 8 analysts, 7 rate the stock a buy — an overall Buy consensus. The stock trades about 2% above its 52-week low.

SciVision Biotech stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of SciVision Biotech over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how SciVision Biotech stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing SciVision Biotech's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

SciVision Biotech Stock Price History
DateSciVision Biotech Price
8/3/202649.70 TWD
7/31/202649.55 TWD
7/30/202648.50 TWD
7/29/202648.50 TWD
7/28/202649.20 TWD
7/27/202650.30 TWD
7/24/202649.95 TWD
7/23/202650.40 TWD
7/22/202650.00 TWD
7/21/202650.80 TWD
7/20/202650.60 TWD
7/17/202651.20 TWD
7/16/202652.40 TWD
7/15/202653.10 TWD
7/14/202652.00 TWD
7/13/202654.50 TWD
7/10/202656.00 TWD
7/9/202656.00 TWD
7/8/202653.50 TWD
7/7/202653.80 TWD
7/6/202654.40 TWD
7/3/202654.30 TWD
7/2/202653.80 TWD
7/1/202653.50 TWD
6/30/202653.70 TWD
6/29/202654.10 TWD
6/26/202652.60 TWD
6/25/202653.40 TWD
6/24/202653.30 TWD
6/23/202652.90 TWD
6/22/202653.70 TWD
6/18/202653.50 TWD
6/17/202653.90 TWD
6/16/202654.30 TWD
6/15/202656.00 TWD
6/12/202656.40 TWD
6/11/202656.70 TWD
6/10/202656.90 TWD
6/9/202660.80 TWD
6/8/202660.60 TWD
6/5/202655.10 TWD
6/4/202654.90 TWD
6/3/202654.30 TWD
6/2/202654.50 TWD
6/1/202654.80 TWD
5/29/202652.60 TWD
5/28/202652.20 TWD
5/27/202653.30 TWD
5/26/202653.60 TWD
5/25/202655.10 TWD
5/22/202658.20 TWD
5/21/202659.50 TWD
5/20/202659.30 TWD
5/19/202660.00 TWD
5/18/202660.00 TWD
5/15/202656.00 TWD
5/14/202651.50 TWD
5/13/202654.40 TWD
5/12/202654.20 TWD
5/11/202656.00 TWD
5/8/202656.80 TWD
5/7/202657.60 TWD
5/6/202658.10 TWD
5/5/202656.20 TWD
5/4/202655.90 TWD
4/30/202657.50 TWD
4/29/202658.30 TWD
4/28/202660.60 TWD
4/27/202661.40 TWD
4/24/202661.00 TWD
4/23/202663.50 TWD
4/22/202664.10 TWD
4/21/202664.50 TWD
4/20/202664.20 TWD
4/17/202663.40 TWD
4/16/202664.90 TWD
4/15/202663.40 TWD
4/14/202663.80 TWD
4/13/202660.70 TWD
4/10/202660.00 TWD
4/9/202659.30 TWD
4/8/202661.10 TWD
4/7/202660.00 TWD
4/2/202660.70 TWD
4/1/202659.40 TWD
3/31/202662.50 TWD
3/30/202663.70 TWD
3/27/202665.20 TWD
3/26/202665.00 TWD
3/25/202665.30 TWD
3/24/202665.20 TWD
3/23/202664.00 TWD
3/20/202664.20 TWD
3/19/202664.90 TWD
3/18/202666.20 TWD
3/17/202665.80 TWD
3/16/202665.40 TWD
3/13/202665.70 TWD
3/12/202666.40 TWD
3/11/202667.60 TWD
3/10/202667.50 TWD
3/9/202666.00 TWD
3/6/202670.10 TWD
3/5/202670.30 TWD
3/4/202667.60 TWD
3/3/202672.00 TWD
3/2/202672.60 TWD
2/26/202674.60 TWD
2/25/202674.10 TWD
2/24/202674.10 TWD
2/23/202675.50 TWD
2/11/202671.60 TWD
2/10/202672.20 TWD
2/9/202672.60 TWD
2/6/202673.60 TWD
2/5/202675.10 TWD
2/4/202675.20 TWD
2/3/202676.10 TWD
2/2/202676.50 TWD
1/30/202678.50 TWD
1/29/202681.20 TWD
1/28/202682.30 TWD
1/27/202679.60 TWD
1/26/202680.50 TWD
1/23/202680.60 TWD
1/22/202679.80 TWD
1/21/202679.20 TWD
1/20/202680.20 TWD
1/19/202681.80 TWD
1/16/202679.30 TWD
1/15/202679.80 TWD
1/14/202679.50 TWD
1/13/202679.10 TWD
1/12/202676.90 TWD
1/9/202675.60 TWD
1/8/202675.50 TWD
1/7/202676.70 TWD
1/6/202671.90 TWD
1/5/202672.00 TWD
1/2/202673.00 TWD
12/31/202572.60 TWD
12/30/202573.70 TWD
12/29/202573.70 TWD
12/26/202573.40 TWD
12/24/202574.80 TWD
12/23/202575.00 TWD
12/22/202575.00 TWD
12/19/202575.20 TWD
12/18/202575.30 TWD
12/17/202574.50 TWD
12/16/202574.20 TWD
12/15/202574.60 TWD
12/12/202574.60 TWD
12/11/202575.90 TWD
12/10/202576.40 TWD
12/9/202576.40 TWD
12/8/202577.40 TWD
12/5/202578.90 TWD
12/4/202579.60 TWD
12/3/202578.80 TWD
12/2/202579.00 TWD
12/1/202580.50 TWD
11/28/202581.10 TWD
11/27/202582.30 TWD
11/26/202581.50 TWD
11/25/202581.40 TWD
11/24/202579.00 TWD
11/21/202577.80 TWD
11/20/202576.50 TWD
11/19/202576.20 TWD
11/18/202576.00 TWD
11/17/202576.90 TWD
11/14/202574.40 TWD
11/13/202574.50 TWD
11/12/202582.50 TWD
11/11/202582.30 TWD
11/10/202583.20 TWD
11/7/202583.50 TWD
11/6/202585.10 TWD
11/5/202585.10 TWD
11/4/202587.70 TWD
11/3/202589.00 TWD
10/31/202590.00 TWD
10/30/202589.70 TWD
10/29/202589.40 TWD
10/28/202590.10 TWD
10/27/202591.90 TWD
10/23/202592.40 TWD
10/22/202594.00 TWD
10/21/202593.60 TWD
10/20/202594.10 TWD
10/17/202596.30 TWD
10/16/202595.90 TWD
10/15/202595.00 TWD
10/14/202593.50 TWD
10/13/2025100.50 TWD
10/9/2025109.00 TWD
10/8/2025109.50 TWD
10/7/2025110.50 TWD
10/3/2025105.00 TWD
10/2/2025103.50 TWD
10/1/2025102.50 TWD
9/30/2025101.50 TWD
9/26/202598.20 TWD
9/25/202596.20 TWD
9/24/202594.60 TWD
9/23/202594.00 TWD
9/22/202591.10 TWD
9/19/202592.20 TWD
9/18/202592.50 TWD
9/17/202591.20 TWD
9/16/202591.10 TWD
9/15/202589.40 TWD
9/12/202591.50 TWD
9/11/202588.30 TWD
9/10/202588.50 TWD
9/9/202588.50 TWD
9/8/202588.20 TWD
9/5/202589.20 TWD
9/4/202589.70 TWD
9/3/202590.10 TWD
9/2/202589.20 TWD
9/1/202589.00 TWD
8/29/202589.60 TWD
8/28/202591.40 TWD
8/27/202592.10 TWD
8/26/202592.30 TWD
8/25/202591.00 TWD
8/22/202590.80 TWD
8/21/202588.80 TWD
8/20/202587.60 TWD
8/19/202588.70 TWD
8/18/202590.00 TWD
8/15/202590.90 TWD
8/14/202592.90 TWD
8/13/202592.70 TWD
8/12/202593.30 TWD
8/11/202593.30 TWD
8/8/202595.00 TWD
8/7/202593.00 TWD
8/6/202593.50 TWD
8/5/2025103.50 TWD
Access this data via the Eulerpool API
Get Free API Key

SciVision Biotech Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
329.58 M TWD
83.34 M TWD
86.87 M TWD
Jan 1, 2019
437.87 M TWD
140.68 M TWD
120.70 M TWD
Jan 1, 2020
466.88 M TWD
161.90 M TWD
128.01 M TWD
Jan 1, 2021
505.54 M TWD
124.25 M TWD
101.72 M TWD
Jan 1, 2022
557.35 M TWD
176.23 M TWD
141.72 M TWD
Jan 1, 2023
712.99 M TWD
199.64 M TWD
177.90 M TWD
Jan 1, 2024
883.31 M TWD
248.11 M TWD
242.25 M TWD
Jan 1, 2025
886.62 M TWD
189.92 M TWD
162.34 M TWD

SciVision Biotech Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 4, 2026, 7:28 PM
 
REVENUEM TWD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM TWD
EBITM TWD
EBIT MARGIN%
NET INCOMEM TWD
NET INCOME GROWTH%
DIV.TWD
DIV. GROWTH%
SHARESM
2010201120122013201420152016201720182019202020212022202320242025
66.00143.00200.00200.00158.00264.00228.00258.00329.00437.00466.00505.00557.00712.00883.00886.00
340.00116.6739.86–-21.0067.09-13.6413.1627.5232.836.648.3710.3027.8324.020.34
34.8562.9461.5057.5050.0058.7155.7058.9165.6569.7973.6167.5266.6171.9174.1872.01
23.0090.00123.00115.0079.00155.00127.00152.00216.00305.00343.00341.00371.00512.00655.00638.00
-12.0043.0050.0031.00-22.0047.00-25.0026.0083.00140.00161.00124.00176.00199.00248.00189.00
-18.1830.0725.0015.50-13.9217.80-10.9610.0825.2332.0434.5524.5531.6027.9528.0921.33
-6.0051.0062.0040.00-22.0054.00-26.0017.0086.00120.00128.00101.00141.00177.00242.00162.00
-88.46-950.0021.57-35.48-155.00-345.45-148.15-165.38405.8839.536.67-21.0939.6025.5336.72-33.06
––––0.65–0.50–0.200.751.300.881.421.984.913.24
–––––––––275.0073.33-32.3161.3639.44147.98-34.01
42.6952.7452.3053.3352.8260.9159.9246.5660.5666.5065.8870.9866.0084.0978.0173.20
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales SciVision Biotech generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue SciVision Biotech retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare SciVision Biotech's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares SciVision Biotech has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against SciVision Biotech's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

SciVision Biotech stock margins

The SciVision Biotech margin analysis displays the gross margin, EBIT margin, as well as the profit margin of SciVision Biotech. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for SciVision Biotech.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
65.82 %
25.29 %
26.36 %
Jan 1, 2019
69.76 %
32.13 %
27.57 %
Jan 1, 2020
73.53 %
34.68 %
27.42 %
Jan 1, 2021
67.62 %
24.58 %
20.12 %
Jan 1, 2022
66.72 %
31.62 %
25.43 %
Jan 1, 2023
71.88 %
28.00 %
24.95 %
Jan 1, 2024
74.23 %
28.09 %
27.43 %
Jan 1, 2025
72.00 %
21.42 %
18.31 %

SciVision Biotech Stock Revenue, EBIT, Earnings per Share

The SciVision Biotech earnings per share therefore indicates how much revenue SciVision Biotech has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2018
5.44 TWD
1.38 TWD
1.43 TWD
Jan 1, 2019
6.58 TWD
2.12 TWD
1.81 TWD
Jan 1, 2020
7.09 TWD
2.46 TWD
1.94 TWD
Jan 1, 2021
7.12 TWD
1.75 TWD
1.43 TWD
Jan 1, 2022
8.44 TWD
2.67 TWD
2.15 TWD
Jan 1, 2023
8.48 TWD
2.37 TWD
2.12 TWD
Jan 1, 2024
11.32 TWD
3.18 TWD
3.11 TWD
Jan 1, 2025
12.11 TWD
2.59 TWD
2.22 TWD

SciVision Biotech business model & stock analysis

SciVision Biotech Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

SciVision Biotech historical P/E ratio, EBIT multiple, and P/S ratio

SciVision Biotech annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

SciVision Biotech shares outstanding

The number of shares of SciVision Biotech was 73.2 M in 2025. This indicates how many shares SciVision Biotech is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2018
60.56 M Stocks
Jan 1, 2019
66.50 M Stocks
Jan 1, 2020
65.88 M Stocks
Jan 1, 2021
70.98 M Stocks
Jan 1, 2022
66.00 M Stocks
Jan 1, 2023
84.09 M Stocks
Jan 1, 2024
78.01 M Stocks
Jan 1, 2025
73.20 M Stocks

SciVision Biotech stock splits

In SciVision Biotech's history, there have been no stock splits.

SciVision Biotech Dividend History

11 years of dividend payments

YearAnnual DividendYoY ChangePayments
20261.91TWDYTD—1×
Apr 29, 20261.91TWD↓ 41.1%1/1
20253.24TWD↓ 34.0%1×
Apr 25, 20253.24TWD↑ 34.6%1/1
20244.91TWD↑ 147.8%2×
20231.98TWD↑ 39.7%1×
20221.42TWD↑ 60.2%1×
20210.88TWD↓ 31.9%1×
20201.30TWD↑ 74.3%1×
20190.75TWD↑ 272.7%1×
20180.20TWD↓ 60.0%1×
20160.50TWD↓ 23.6%1×

SciVision Biotech dividend history and estimates

In 2025, SciVision Biotech paid a dividend amounting to 3.24 TWD. Dividend means that SciVision Biotech distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2018
0.20 TWD
0.00 TWD
Jan 1, 2019
0.75 TWD
0.00 TWD
Jan 1, 2020
1.30 TWD
0.00 TWD
Jan 1, 2021
0.88 TWD
0.00 TWD
Jan 1, 2022
1.42 TWD
0.00 TWD
Jan 1, 2023
1.98 TWD
0.00 TWD
Jan 1, 2024
4.91 TWD
0.00 TWD
Jan 1, 2025
3.24 TWD
0.00 TWD

SciVision Biotech dividend payout ratio

In 2025, SciVision Biotech had a payout ratio of 146.07%. The payout ratio indicates the percentage of the company's profits that SciVision Biotech distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2018
11.99 %
Jan 1, 2019
41.33 %
Jan 1, 2020
61.63 %
Jan 1, 2021
66.98 %
Jan 1, 2022
66.02 %
Jan 1, 2023
93.60 %
Jan 1, 2024
81.56 %
Jan 1, 2025
146.07 %

Current SciVision Biotech forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
87.50 % (7)
Hold
12.50 % (1)
Sell
0.00 % (0)
12M Price Target
148.92
Last Price
49.70
Currency
TWD
12M Return Potential
199.64 %
LTM Return
0 %

SciVision Biotech shareholder structure

% Name
0.78749%
Dimensional Fund Advisors, L.P.
Dimensional Fund Advisors, L.P.
0.19622%
State Street Investment Management (US)
State Street Investment Management (US)
0.13905%
Mellon Investments Corporation
Mellon Investments Corporation
0.08057%
Dimensional Fund Advisors, Ltd.
Dimensional Fund Advisors, Ltd.
0.00330%
Keyridge Asset Management Limited
Keyridge Asset Management Limited
0.00260%
American Century Investment Management, Inc.
American Century Investment Management, Inc.

SciVision Biotech Beneficial Ownership Filings (SEC 13D/G)

Free Float
71.5%
Float Shares
-
Shares Outstanding
-

SciVision Biotech Executives and Management Board

12 members

Management

RG

Ruling Guo

Deputy General Manager, Head of Finance & Accounting

–
HX

Huiwen Xu

Corporate Governance Officer

–

Board of Directors

KH

Kaicheng Han

Chairman of the Board, General Manager · since 2002

–
ZP

Zongwei Pan

Deputy General Manager, Director · since 2020

–
GF

Guojian Fang

Director

–
TH

Taiwei Han

Director

–
JH

Jieqing Huang

Director

–
MY

Minggong Yang

Director

–

Frequently asked questions about SciVision Biotech

Analysts currently set an average price target of 148.92 TWD for the SciVision Biotech stock (median: 148.92 TWD), implying +199.6 % versus the latest price. The consensus is based on 8 analyst ratings.

SciVision Biotech Analyst Price Targets 2026

7 analysts currently rate the SciVision Biotech stock: 6 recommend buying, 1 holding and 0 selling.

SciVision Biotech Analyst Price Targets 2026

Converted at the current exchange rate, the SciVision Biotech share trades at 1.33 EUR (49.70 TWD).

No history available for SciVision Biotech.

The revenue cannot currently be calculated for SciVision Biotech.

The profit cannot currently be calculated for SciVision Biotech.

The P/E ratio cannot be calculated for SciVision Biotech at the moment.

The P/S cannot be calculated for SciVision Biotech currently.

The Eulerpool Quality Score for SciVision Biotech is 5/10.

The ISIN of SciVision Biotech is TW0001786002. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of SciVision Biotech is 1786.TW. The ticker symbol is used to trade SciVision Biotech shares on the stock exchange.

Over the past 12 months, SciVision Biotech paid a dividend of 3.24 TWD . This corresponds to a dividend yield of about 6.52 %. For the coming 12 months, SciVision Biotech is expected to pay a dividend of 3.24 TWD.

The current dividend yield of SciVision Biotech is 6.52 %.

SciVision Biotech pays a dividend, distributed in the months of , , , .

SciVision Biotech paid dividends every year for the past 8 years.

For the upcoming 12 months, dividends amounting to 3.24 TWD are expected. This corresponds to a dividend yield of 6.52 %.

SciVision Biotech is assigned to the 'Health' sector.

To receive the latest dividend of SciVision Biotech from amounting to 1.91 TWD, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, SciVision Biotech distributed 2.53 TWD as dividends.

The dividends of SciVision Biotech are distributed in TWD.

All fundamentals and in-depth analysis of SciVision Biotech

Our stock analysis for SciVision Biotech stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of SciVision Biotech. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

SciVision Biotech Stock
SciVision Biotech Revenue→
SciVision Biotech Stock
SciVision Biotech Net Income→
SciVision Biotech Stock
SciVision Biotech P/E→
SciVision Biotech Stock
SciVision Biotech P/S→
SciVision Biotech Stock
SciVision Biotech EBIT→
SciVision Biotech Stock
SciVision Biotech Dividend→
SciVision Biotech Stock
SciVision Biotech Directors Dealings→
SciVision Biotech Stock
SciVision Biotech Stocks→
SciVision Biotech Stock
SciVision Biotech Market capitalization→
SciVision Biotech Stock
SciVision Biotech Debt→
SciVision Biotech Stock
SciVision Biotech Liabilities→
SciVision Biotech Stock
SciVision Biotech Equity→
SciVision Biotech Stock
SciVision Biotech AAQS→
SciVision Biotech Stock
SciVision Biotech Employees→
SciVision Biotech Stock
SciVision Biotech ROE→
SciVision Biotech Stock
SciVision Biotech ROA→
SciVision Biotech Stock
SciVision Biotech ROCE→
SciVision Biotech Stock
SciVision Biotech News→
SciVision Biotech Stock
SciVision Biotech Analyst Price Targets→

Health Stocks

SCL ScienceScisparcSCM LifeScience CoScinoPharm TaiwanScope FluidicsScientific IndustriesScopus BiopharmaScientific and Medical Equipment House Company CJSCScorpius HoldingsSciClone Pharmaceuticals (Holdings)ScrybSciBase Holding AB (publ)All Stocks A–Z →